Vascular Biogenics (VBLT) Priced

Developing gene therapies for cancer and small molecules for inflammation.

Health Care - Biotechnology

IPO Performance
Latest Trade $5.80 0.00 (0.0%)
First Day Return -2.5%
Return from IPO -3.3%
 
Vascular Biogenics IPO News more
  • .
IPO Data
IPO File Date 06/06/2014
Offer Price $6.00
Price Range $13.00 - $15.00
Offer Shares (mm) 6.7
Deal Size ($mm) 40
 
IPO Data
IPO Date 09/30/2014
Offer Price $6.00
Price Range $13.00 - $15.00
Offer Shares (mm) 6.7
Deal Size ($mm) $40
 
Underwriters
more
Business Overview
Developing gene therapies for cancer and small molecules for inflammation.
Developing gene therapies for cancer and small molecules for inflammation.
more
Company Data
Headquarters Or Yehuda, , Israel
Founded 2000
Employees 32
Website www.vblrx.com
 

Performance vs. IPO Index (IPOUSA)